SCHEMBL829036

SCHEMBL829036

CNC(=O)/C(=N\OC)c1ccccc1COc1ncc(Cl)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 8/20 0.49
MRGPRX4 Q96LA9 2/20 0.40
SGMS2 Q8NHU3 2/20 0.39
SCN9A Q15858 1/20 0.38
PSMB5 P28074 1/20 0.38
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
F10 P00742 1/20 0.36
TP53 P04637 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL829037 1.00 HIF1A (0.49) HIF1AMRGPRX4SGMS2SCN9APSMB5
SCHEMBL8343054 0.89 HIF1A (0.46) HIF1AMRGPRX4SCN9ALMNATP53
SCHEMBL8337628 0.89 HIF1A (0.45) HIF1AMRGPRX4SCN9ATP53HTT
SCHEMBL8337626 0.89 HIF1A (0.45) HIF1AMRGPRX4SCN9ATP53HTT
SCHEMBL8343050 0.89 HIF1A (0.46) HIF1AMRGPRX4SCN9ALMNATP53
SCHEMBL829098 0.88 HIF1A (0.46) HIF1AMRGPRX4SGMS2POLB
SCHEMBL829099 0.88 HIF1A (0.46) HIF1AMRGPRX4SGMS2POLB
SCHEMBL8105497 0.88 HIF1A (0.46) HIF1AMRGPRX4SGMS2POLB
SCHEMBL8370602 0.88 HIF1A (0.50) HIF1AMRGPRX4SCN9ALMNAPOLB
SCHEMBL7521316 0.88 HIF1A (0.45) HIF1AMRGPRX4SCN9ATP53HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143275-B2 Use of triazolopyrimidine derivatives as microbicides LANXESS DEUTSCHLAND GMBH (DE) 2012-03-27 US disclosed
US-20110098279-A1 USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES LANXESS DEUTSCHLAND GMBH (DE) 2011-04-28 US disclosed
US-7888371-B2 For protecting engineered wood, timber, or plastic from phytopathogenic fungi LANXESS DEUTSCHLAND GMBH (DE) 2011-02-15 US disclosed
EP-1395117-B2 USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES IN THE PROTECTION OF MATERIALS LANXESS DEUTSCHLAND GMBH (DE) 2009-09-30 EP disclosed
US-7084137-B2 Thiazines and thiazoles as agents for protecting materials BAYER AKTIENGESELLSCHAFT (DE) 2006-08-01 US disclosed
EP-1395117-B1 USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES IN THE PROTECTION OF MATERIALS LANXESS DEUTSCHLAND GMBH (DE) 2006-07-26 EP disclosed
US-6835842-B2 Microbiocides; bactericides BAYER AKTIENGESELLSCHAFT (DE) 2004-12-28 US disclosed
US-20040204405-A1 Thiazines and thiazoles as agents for protecting materials LANXESS DEUTSCHLAND GMBH (DE) 2004-10-14 US disclosed
EP-1437940-A1 THIAZINES AND THIAZOLES FOR USE AS MATERIAL PROTECTIVE AGENTS Bayer Chemicals AG (DE) 2004-07-21 EP disclosed
EP-1395117-A1 USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES IN THE PROTECTION OF MATERIALS Bayer Chemicals AG (DE) 2004-03-10 EP disclosed
EP-0975611-A1 3-ALKOXY ISOTHIAZOLES BAYER AG (DE) 2000-02-02 EP disclosed
WO-1999062911-A1 PYRIDODITHIAZINE DIOXIDES BAYER AKTIENGESELLSCHAFT (DE) 1999-12-09 WO disclosed
EP-0950055-A1 ARYLTHIO-DITHIAZINDIOXIDES AND THEIR USE AS PESTICIDES BAYER AG (DE) 1999-10-20 EP disclosed
EP-0617011-B1 Process for producing alkoxyiminoacetamide compounds SHIONOGI & CO (JP) 1999-01-20 EP disclosed
WO-1998045258-A1 1-CYANO-2-ALKYLTHIO-2-ARYLTHIOETHENES BAYER AKTIENGESELLSCHAFT (DE) 1998-10-15 WO disclosed
WO-1998042689-A1 3-ALKOXY ISOTHIAZOLES BAYER AKTIENGESELLSCHAFT (DE) 1998-10-01 WO disclosed
WO-1998039969-A1 ALGICIDAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 1998-09-17 WO disclosed
WO-1998029400-A1 ARYLTHIO-DITHIAZINDIOXIDES AND THEIR USE AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-07-09 WO disclosed
US-5506358-A USEFUL AS AGRICULTURAL FUNGICIDES SHIONOGI & CO., LTD. (JP) 1996-04-09 US disclosed
EP-0617011-A2 Process for producing alkoxyiminoacetamide compounds SHIONOGI & CO., LTD. (JP) 1994-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040204405-A1 Thiazines and thiazoles as agents for protecting materials POT1, NAT1, GPX1 HIF1A 2331/4885MRGPRX4 2783/4885SGMS2 3897/4885
US-20110098279-A1 USE OF TRIAZOLOPYRIMIDINE DERIVATIVES AS MICROBICIDES ARG2, MSR1, TK2 HIF1A 1989/4885MRGPRX4 22/4885SGMS2 1753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.